Total planned funding: $161,271,588
Allocations
Countries/Regions
India | $161,271,588 |
Organizational Types
NGO | $69,849,511 |
Unknown | $34,092,862 |
Own Agency | $29,027,512 |
University | $17,791,895 |
Multi-lateral Agency | $4,366,808 |
FBO | $2,700,000 |
Private Contractor | $1,659,000 |
Other USG Agency | $1,034,600 |
Host Country Government Agency | $749,400 |
Implementing Agency | $0 |
Program Areas
Governance and Systems | $61,277,677 |
Prevention | $38,916,887 |
Care | $20,653,309 |
Management and Operations | $19,650,200 |
Treatment | $9,172,939 |
Testing | $7,172,784 |
Budget Codes
OHSS: Health Systems Strengthening | $32,961,569 |
HVOP: Sexual Prevention: Other Sexual Prevention | $22,223,601 |
HVSI: Strategic Information | $20,317,491 |
HVMS: Management and Operations | $19,650,200 |
HBHC: Care: Adult Care and Support | $11,689,789 |
HTXS: Treatment: Adult Treatment | $8,463,314 |
HLAB: Laboratory Infrastructure | $7,998,617 |
HVCT: Testing: HIV Testing and Counseling | $7,172,784 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $6,246,097 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $5,414,806 |
HVTB: Care: TB/HIV | $4,866,123 |
HKID: Care: Orphans and Vulnerable Children | $3,401,345 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $2,893,135 |
HMBL: Biomedical Prevention: Blood Safety | $2,129,248 |
PDCS: Care: Pediatric Care and Support | $696,052 |
PDTX: Treatment: Pediatric Treatment | $686,148 |
HTXD: Treatment: ARV Drugs | $23,477 |
HMIN: Biomedical Prevention: Injection Safety | $10,000 |
Top Partner Programs
Not Available:
$32,420,884
Countries/Regions
FHI 360:
$24,764,228
Countries/Regions
USG Aggregated Agencies:
$15,957,191
Countries/Regions
Voluntary Health Services:
$13,430,000
Countries/Regions